|
Market Closed -
Nasdaq
00:00:00 22/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 17.10 USD | -3.77% |
|
+0.88% | +32.25% |
| 07-24 | Wedbush Adjusts Price Target on NovoCure to $20 From $18, Maintains Neutral Rating | MT |
| 07-23 | NovoCure Limited, Q2 2026 Earnings Call, Jul 23, 2026 |
Chart: Technical Analysis
Stock exchange
Nasdaq
NVCR 17.10 $
-3.77%
24.01M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| NVCR | 17.10USD | -3.77% | 24.01M $ | |
CBOE
| NVCR | 17.09USD | -3.77% | 805K $ | |
|
Tradegate
| 038 | 14.64EUR | -3.75% | 1.32K € | |
|
Deutsche Boerse AG
| 038 | 14.91EUR | -1.75% | 0 € | |
|
Börse Stuttgart
| 038 | 14.65EUR | -3.71% | 0 € | |
|
Boerse Muenchen
| 038 | 14.64EUR | -3.91% | 0 € | |
Sao Paulo
| N2VC34 | 8.900BRL | -2.09% | 17.8 R$ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 19.99 | 19.99 | 17.96 |
| Spread/Res. | -14.46% | -14.46% | -4.79% |
| Spread/Supp. | +15.23% | +25.64% | +25.09% |
| Support | 14.84 | 13.61 | 13.67 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NVCR Stock
- Charts NovoCure Limited
Select your edition
All financial news and data tailored to specific country editions
